International Conference on Metabolomics
Cenetri Publishing Group looks forward to welcome all the participants across the Globe to attend "International Conference on Metabolomics" during February 26-28, 2018 at Bangkok, Thailand. The conference highlights the theme "Advancing Aspects in the Field of Metabolomics and Systems Biology". This Conference aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Metabolomics. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Metabolomics. We look forward to seeing you along with thousands of your colleagues from around the globe in Bangkok
Scope and Importance
The conference program covers a wide range of topics related to metabolomics while focusing on Health Problems. This metabolomics congress offers key insights into cutting-edge applications from global experts related to Metabolomics.
Metabolomics is an emerging field which combines strategies to identify and quantify cellular metabolites using sophisticated analytical technologies with the application of statistical and multi-variant methods for information extraction and data interpretation. Metabolomics is the study of small metabolites. Metabolomics Conference deals with topics like Bioinformatics, proteomics, systems biology, Analytical Techniques like NMR, GC-MS, LC-MS and CE-MS, Lipidomics, Metabolic Modelling, Metabolic profiling, clinical metabolomics, Translational sciences, Mass spectrometry, Metabolomics Syndrome, HPLC and CE based metabolomics and more. Metabolomics - the new omics - is a dynamic and developing field, joining genomics, transcriptomics and proteomics in empowering an integrative frameworks science methodology to drug discovery and development. In spite of the fact that metabolomics is still at an early evolutionary stage it is conjecture that throughout the following decade the biopharma business will apply this innovation all the more generally in drug development and information.
'The Future of Metabolomics' gives fully fledged understanding into the compelling utilization of metabolomics all through drug discovery, preclinical development and clinical trials. The report also highlights the use of metabolomics in maximizing and sustaining revenues post-marketing and in the development of clinical diagnostics.